What is Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) share price return in the past 10 years?

Aarey Drugs & Pharmaceuticals Ltd share price has appreciated 4.5% annually (CAGR) over the past ten years.

What is the share price of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)?

Company share prices are keep on changing according to the market conditions. The current trading price of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) on 04-Jun-2026 16:59:59 at 16:59 is 78.50.

What is the P/E ratio of Aarey Drugs & Pharmaceuticals?

The latest standalone P/E ratio of Aarey Drugs & Pharmaceuticals as of 04-Jun-2026 is 56.09.

What is the P/B ratio of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)?

The latest standalone P/B ratio of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) as of 04-Jun-2026 is 1.53.

What is the 52-week high and low of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)?

The 52-week high of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) is Rs. 100.00 and the 52-week low is Rs. 49.01.

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)
Brand: Aarey Drugs & Pharmaceuticals

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524412 NSE: AAREYDRUGS Trading | Small Cap | Aarey Drugs & Pharma Share Price

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524412 NSE: AAREYDRUGS Trading | Small Cap | Aarey Drugs & Pharma Share Price

Key Metrics

Valuation Multiples

Market Cap

₹223 Cr.

Current Price

₹78.5

52-Week Low / High

₹49 / 100

TTM EPS

₹1.4

TTM Sales

₹472 Cr.

Book Value per Share

₹51.3

P/E Ratio

56.09

Higher than its 5-year historical median

Industry PE

Price to Book (P/B)

1.53

Higher than its 5-year historical median

Price to Sales (P/S)

0.47

Higher than its 5-year historical median

EV/EBITDA

20.43

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

3.02%

Outperforms industry median

Return on Capital Employed (ROCE)

6.38%

Outperforms industry median

Return on Assets (ROA)

1.36%

Operating Profit Margin

0.6%

Net Profit Margin

0.85%

Gross Profit Margin

1.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

19.19%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-55.25%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

-14.1%

Asset Quality

Promoter Holding

37.71%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹117 Cr.

Equity

₹28.4 Cr.

Face Value

₹10

All Time Low / High

₹0.50 / 143.95

Aarey Drugs & Pharmaceuticals stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Aarey Drugs & Pharmaceuticals Ltd a good quality company?

Aarey Drugs & Pharmaceuticals Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Aarey Drugs & Pharmaceuticals Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Aarey Drugs & Pharmaceuticals Ltd vs industry peers?

Aarey Drugs & Pharmaceuticals Ltd revenue CAGR is 9.57%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Aarey Drugs & Pharmaceuticals Ltd?

Promoters hold 37.71% of the Aarey Drugs & Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Aarey Drugs & Pharmaceuticals Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 6.2% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	7.2%	22.2%	14.1%	12.1%	8.5%	9.5%	9.9%	6.3%	6.1%	6.4%	-
Value Creation Index ⓘ	-0.5	0.6	0.0	-0.1	-0.4	-0.3	-0.3	-0.6	-0.6	-0.5	-
Growth Parameters ⓘ
Sales ⓘ	246	396	349	355	300	348	493	419	398	474	472
Sales YoY Gr.	-	60.9%	-12%	1.7%	-15.4%	16.1%	41.4%	-15%	-5.1%	19.2%	-
Adj EPS ⓘ	0.8	3	2.6	2.8	2.5	2.8	2.6	1.6	1.7	1.4	1.4
YoY Gr.	-	297.4%	-15.6%	9.4%	-11.1%	12.1%	-7.6%	-37.4%	3.7%	-16.2%	-
BVPS (₹) ⓘ	21.8	26.6	33.3	36	38.5	41.3	43.9	45.3	46.5	47.8	51.3
Adj Net Profit ⓘ	1.3	5.5	6	6.5	5.8	6.5	6.5	4.1	4.7	4	4
Cash Flow from Ops. ⓘ	5.7	0.6	-20.4	0.7	2.9	5.5	0.5	-1.3	-3	10.3	-
Debt/CF from Ops. ⓘ	2.6	16.6	-0.2	23.5	6.3	3.3	28.4	-29.4	-10.5	3.4	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	7.6%	9.6%	-1.3%	19.2%
Adj EPS ⓘ	7%	-10.8%	-18.3%	-16.2%
BVPSⓘ	9.1%	4.4%	2.9%	2.9%
Share Price	4.5%	18.1%	35.9%	48.8%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	3.5	12.7	9.2	7.8	6.5	6.8	6.1	3.5	3.8	2.9	2.8
Op. Profit Mgn % ⓘ	0.4	2.4	2.2	2.2	1.1	1.3	2.3	2	1.6	0.6	1.5
Net Profit Mgn % ⓘ	0.5	1.4	1.7	1.8	1.9	1.9	1.3	1	1.2	0.8	0.8
Debt to Equity ⓘ	0.4	0.2	0	0.2	0.2	0.2	0.1	0.3	0.2	0.3	0
Working Cap Days ⓘ	166	112	148	147	191	209	166	221	259	215	100
Cash Conv. Cycle ⓘ	3	6	24	63	74	54	38	58	83	65	44

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	246	396	349	355	300	348	493	419	398	474
Operating Expenses ⓘ +	245	386	341	347	297	344	481	411	391	471
Manufacturing Costs	1	0	0	2	2	5	9	8	11	10
Material Costs	242	383	337	341	290	334	466	398	375	454
Employee Cost	0	0	0	0	0	0	1	1	1	1
Other Costs ⓘ	2	3	3	3	5	4	6	5	4	6
Operating Profit ⓘ	1	10	8	8	3	5	11	8	6	3
Operating Profit Margin (%)	0.4%	2.4%	2.2%	2.2%	1.1%	1.3%	2.3%	1.8%	1.6%	0.6%
Other Income ⓘ +	3	3	3	4	7	7	3	3	5	10
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2	4	2	2	2	2	2	3	4	5
Depreciation ⓘ	1	1	1	1	1	1	2	2	2	2
Profit Before Tax ⓘ	2	8	8	9	7	8	10	6	5	6
Tax ⓘ	1	3	2	2	1	2	3	2	1	2
Profit After Tax	1	5	6	7	6	7	7	4	5	4
PAT Margin (%)	0.5%	1.4%	1.8%	1.8%	1.9%	1.9%	1.3%	0.9%	1.2%	0.9%
Adjusted EPS (₹)	0.8	3.0	2.6	2.8	2.5	2.8	2.6	1.5	1.7	1.4
Dividend Payout Ratio (%)	0%	0%	0%	3.60%	0%	0%	0%	0%	0%	0%

Valuation of Aarey Drugs & Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	37	48	78	84	90	97	111	115	130	136
Share Capital ⓘ	17	18	23	23	23	23	25	25	28	28
Reserves ⓘ	20	30	55	61	67	73	86	90	102	108
Debt +	15	10	3	16	18	18	14	38	31	35
Long Term Debt	0	0	0	0	0	0	3	4	3	2
Short Term Debt	14	10	3	16	18	18	11	33	28	33
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	72	75	78	37	78	110	110	127	129	103
Others Liabilities ⓘ	2	9	11	8	8	8	10	11	13	17
Total Liabilities ⓘ	125	142	170	146	194	233	245	291	303	291
Fixed Assets
Net Fixed Assets ⓘ +	8	12	12	12	12	14	14	14	13	16
Gross Block	19	24	25	26	27	30	32	33	34	40
Accumulated Depreciation	11	12	13	14	15	16	18	19	21	24
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	1	2
Inventories	2	5	15	21	17	18	14	29	35	45
Trade Receivables	72	82	95	106	96	162	136	190	184	133
Cash Equivalents	2	1	3	0	1	1	0	1	2	1
Others Assets ⓘ	41	42	44	6	68	37	80	58	68	92
Total Assets ⓘ	125	142	170	146	194	233	245	291	303	291

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	6	1	-20	1	3	5	0	-1	-3	10
PBT ⓘ	2	8	8	9	7	8	10	6	5	6
Adjustment ⓘ	2	5	3	3	3	3	4	4	5	7
Changes in Working Capital ⓘ	1	-10	-29	-9	-6	-5	-10	-9	-12	-1
Tax Paid ⓘ	0	-2	-3	-2	-2	-2	-4	-2	-1	-2
Cash Flow From Investing Activity ⓘ +	-3	-5	-1	-1	-1	-3	-3	0	-2	-6
Capex	-3	-5	-1	-1	-1	-3	-2	-1	-1	-5
Net Investments	0	-0	0	0	0	0	-1	1	-1	-1
Others ⓘ	0	-0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-2	4	23	-2	-2	-2	2	1	6	-4
Net Proceeds from Shares ⓘ	0	7	24	0	0	0	8	0	11	2
Net Proceeds from Borrowing ⓘ	0	-0	0	0	0	0	-4	4	-1	-2
Interest Paid ⓘ	-2	-4	-2	-2	-2	-2	-2	-3	-4	-5
Dividend Paid ⓘ	0	0	0	-0	0	0	0	0	0	0
Others ⓘ	0	1	2	-0	-0	-0	0	-0	1	0
Net Cash Flow ⓘ	1	-1	2	-3	0	0	-0	1	1	-0

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	3.58	12.9	9.8	8.07	6.65	6.98	6.31	3.33	3.82	3.02
ROCE (%)	7.23	22.21	14.14	12.05	8.48	9.46	9.87	6.28	6.09	6.38
Asset Turnover Ratio	2.05	2.96	2.24	2.25	1.77	1.63	2.06	1.56	1.34	1.6
PAT to CFO Conversion(x)	6	0.2	-3.33	0.14	0.5	0.71	0	-0.25	-0.6	2.5
Working Capital Days
Receivable Days	103.30	71.10	92.60	103.40	122.80	135.20	110.50	142	171.80	122.40
Inventory Days	4.60	3.40	10.40	18.50	23.30	18.60	11.90	18.50	29.10	30.90
Payable Days	104.90	69.80	82.30	61.50	72.30	102.60	86.10	108.80	124.60	93.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Aarey Drugs & Pharmaceuticals Ltd FAQs

The current trading price of Aarey Drugs & Pharma on 04-Jun-2026 16:59 is ₹78.50.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Aarey Drugs & Pharma stood at ₹222.6 Cr

The latest P/E ratio of Aarey Drugs & Pharma as of 03-Jun-2026 is 56.09.

The latest P/B ratio of Aarey Drugs & Pharma as of 03-Jun-2026 is 1.53.

The 52-week high of Aarey Drugs & Pharma is ₹100.0 and the 52-week low is ₹49.01.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarey Drugs & Pharma is ₹472 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aarey Drugs & Pharmaceuticals Ltd is a below average quality company.

The key valuation ratios of Aarey Drugs & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Aarey Drugs & Pharmaceuticals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

The company also export its products to various other countries like Germany, Sri Lanka, Pakistan, Nepal and a number of African countries and is looking to establish its trade relations in other parts of the world as well.

Product range of the company includes: API/Intermediate

Metronidazol
Metronidazole Benzoate
2 Methyl -5-Nitro Imidazole

Drug deliveryPharmaceuticals / Therapeutics

Therapeutic targets of the company's products are:

Allergy
Dermatology
Infectious Diseases

Recent development

Aarey Drugs & Pharmaceuticals has recently informed that Atul A Zatakia has resigned from the Company as a Director with effect from March 01, 2009.

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

Aarey Drugs & Pharmaceuticals stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Aarey Drugs & Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Aarey Drugs & Pharmaceuticals Ltd FAQs

About Aarey Drugs & Pharmaceuticals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

Aarey Drugs & Pharmaceuticals stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Aarey Drugs & Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Aarey Drugs & Pharmaceuticals Ltd FAQs

What is the share price of Aarey Drugs & Pharma?

What is the market cap of Aarey Drugs & Pharma?

What is the P/E ratio of Aarey Drugs & Pharma?

What is the P/B ratio of Aarey Drugs & Pharma?

What is the 52-week high and low of Aarey Drugs & Pharma?

What is the TTM revenue of Aarey Drugs & Pharma?

Is Aarey Drugs & Pharmaceuticals Ltd a good quality company?

Is Aarey Drugs & Pharmaceuticals Ltd undervalued or overvalued?

Is Aarey Drugs & Pharmaceuticals Ltd a good buy now?

About Aarey Drugs & Pharmaceuticals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.